US advisory panel's chairman calls for reversal of breast implant decisionBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7424.1128-c (Published 13 November 2003) Cite this as: BMJ 2003;327:1128
- Fred Charatan
A decision to restore the marketing of silicone breast implants hangs in the balance after a senior medical adviser has called for the move to be reversed.
In an unprecedented step, the chairman of the advisory panel on medical devices to the US Food and Drug Administration, Dr Thomas Whalen, wrote at the end of October to the agency's commissioner, Dr Mark McLellan, and five congressman, urging them to ignore the panel's recommendation.
In October the panel had voted by nine to six in favour of lifting the agency's 1992 ban …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial